This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Agile and adaptable infrastructure to work with partners
We partner in many different ways – licensing or acquisition and special purpose vehicle (SPV)
€505 million net product sales in 2021
Our positive performance in 2021 allows us to reinvest in medicines for the future
Multiple specialist therapy areas
Gastroenterology, hepatology and more
One Norgine approach and infrastructure. Over 1,400 people
We believe that all of our employees contribute to our future success as a company